ATTOM REVEALS BEST DAY TO BUY A HOME BASED ON LOWEST PREMIUM ABOVE AVM

December 4th and November Offer 2024’s Lowest Homebuying Premiums

IRVINE, Calif., Nov. 14, 2024 /PRNewswire/ — ATTOM, a leading curator of land, property data, and real estate analytics, today released its annual analysis highlighting the best days of the year to purchase a home. The report found that while November offers a 7.3 percent premium, it remains the lowest premium for buyers. Additionally, December 4th stands out as the single best day to buy a home.

2024 Best Time to Buy A Home Infographic

According to ATTOM’s latest analysis of more than 52 million single family home and condo sales over the past 11 years, buyers who close on December 4th are seeing the lowest premium above the automated valuation model (AVM). While still above market value, homebuyers are only paying a 4.8 percent premium, compared to the 14.6 percent premium buyers are seeing on May 27th. (Full methodology is enclosed below.)

Other days of the year offering lower premiums for homebuyers include: October 2nd (5.0 percent premium above market value); December 24th (5.1 percent premium); January 16th (5.1 percent premium); November 13th (5.3 percent premium); and October 9th (5.5 percent premium).

ATTOM’s new analysis also looked at the best months to buy at the national level and best months to buy at the state level.

Best Months to Buy
Nationally, the best months to buy are November (7.3 percent premium above market value); October (7.4 percent premium); December (7.6 percent premium); August (8.0 percent premium); and September (8.0 percent premium).

Best Months to Buy by State
According to the study, the states realizing the biggest discounts below full market value are Michigan (-3.2 percent in December); Connecticut (-1.2 percent in January); Hawaii (-1.1 percent in June); Illinois (-0.9 percent in December); and Minnesota (-0.9 percent in December).

Methodology
For this analysis ATTOM looked at any calendar day in the last 11 years (2013 to 2023) with at least 15,000 single family home and condo sales. There were 362 days (including leap year data) that matched these criteria, with the four exceptions being Jan. 1, July 4, Nov. 11, and Dec. 25. To calculate the premium or discount paid on a given day, ATTOM compared the median sales price for homes with a purchase closing on that day with the median automated valuation model (AVM) for those same homes at the time of sale.

About ATTOM 
ATTOM provides premium property data and analytics that power a myriad of solutions that improve transparency, innovation, digitization and efficiency in a data-driven economy. ATTOM multi-sources property tax, deed, mortgage, foreclosure, environmental risk, natural hazard, and neighborhood data for more than 155 million U.S. residential and commercial properties covering 99 percent of the nation’s population. A rigorous data management process involving more than 20 steps validates, standardizes, and enhances the real estate data collected by ATTOM, assigning each property record with a persistent, unique ID — the ATTOM ID. The 30TB ATTOM Data Warehouse fuels innovation in many industries including mortgage, real estate, insurance, marketing, government and more through flexible data delivery solutions that include ATTOM Cloudbulk file licensesproperty data APIsreal estate market trendsproperty navigator and more. Also, introducing our newest innovative solution, making property data more readily accessible and optimized for AI applications – AI-Ready Solutions.

Media Contact:
Megan Hunt
megan.hunt@attomdata.com 

Data and Report Licensing:
datareports@attomdata.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/attom-reveals-best-day-to-buy-a-home-based-on-lowest-premium-above-avm-302304994.html

SOURCE ATTOM

Market News and Data brought to you by Benzinga APIs

source

Positive Signal: Raymond B Greer Shows Faith, Buying $105K In Lifevantage Stock

It was revealed in a recent SEC filing that Raymond B Greer, Board Member at Lifevantage LFVN made a noteworthy insider purchase on November 12,.

What Happened: Greer’s recent purchase of 7,819 shares of Lifevantage, disclosed in a Form 4 filing with the U.S. Securities and Exchange Commission on Tuesday, reflects confidence in the company’s potential. The total transaction value is $105,009.

Monitoring the market, Lifevantage‘s shares up by 0.29% at $13.78 during Wednesday’s morning.

Unveiling the Story Behind Lifevantage

Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.

Lifevantage’s Economic Impact: An Analysis

Revenue Challenges: Lifevantage’s revenue growth over 3 months faced difficulties. As of 30 September, 2024, the company experienced a decline of approximately -8.08%. This indicates a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Consumer Staples sector.

Profitability Metrics: Unlocking Value

  • Gross Margin: Achieving a high gross margin of 79.9%, the company performs well in terms of cost management and profitability within its sector.

  • Earnings per Share (EPS): Lifevantage’s EPS is below the industry average, signaling challenges in bottom-line performance with a current EPS of 0.15.

Debt Management: With a below-average debt-to-equity ratio of 0.48, Lifevantage adopts a prudent financial strategy, indicating a balanced approach to debt management.

Valuation Overview:

  • Price to Earnings (P/E) Ratio: Lifevantage’s stock is currently priced at a premium level, as reflected in the higher-than-average P/E ratio of 42.94.

  • Price to Sales (P/S) Ratio: The P/S ratio of 0.91 is lower than the industry average, implying a discounted valuation for Lifevantage’s stock in relation to sales performance.

  • EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation & Amortization): Lifevantage’s EV/EBITDA ratio, surpassing industry averages at 17.77, positions it with an above-average valuation in the market.

Market Capitalization: Indicating a reduced size compared to industry averages, the company’s market capitalization poses unique challenges.

Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.

Navigating the Impact of Insider Transactions on Investments

In the complex landscape of investment decisions, investors should approach insider transactions as part of a comprehensive analysis, considering various elements.

In the realm of legality, an “insider” is defined as any officer, director, or beneficial owner holding more than ten percent of a company’s equity securities under Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are required to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.

Notably, when a company insider makes a new purchase, it is considered an indicator of their positive expectations for the stock.

Conversely, insider sells may not necessarily signal a bearish stance on the stock and can be motivated by various factors.

Cracking Transaction Codes

Digging into the details of stock transactions, investors frequently turn their attention to those taking place in the open market, as outlined in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.

Check Out The Full List Of Lifevantage’s Insider Trades.

Insider Buying Alert: Profit from C-Suite Moves

Benzinga Edge reveals every insider trade in real-time. Don’t miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. Click here for access.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs

Dayton Judd Of Lifevantage Shows Optimism, Buys $105K In Stock

Dayton Judd, Board Member at Lifevantage LFVN, reported an insider buy on November 12, according to a new SEC filing.

What Happened: Judd’s recent purchase of 7,819 shares of Lifevantage, disclosed in a Form 4 filing with the U.S. Securities and Exchange Commission on Tuesday, reflects confidence in the company’s potential. The total transaction value is $105,009.

The latest market snapshot at Wednesday morning reveals Lifevantage shares up by 0.29%, trading at $13.78.

All You Need to Know About Lifevantage

Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.

Lifevantage: A Financial Overview

Negative Revenue Trend: Examining Lifevantage’s financials over 3 months reveals challenges. As of 30 September, 2024, the company experienced a decline of approximately -8.08% in revenue growth, reflecting a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Consumer Staples sector.

Interpreting Earnings Metrics:

  • Gross Margin: Achieving a high gross margin of 79.9%, the company performs well in terms of cost management and profitability within its sector.

  • Earnings per Share (EPS): Lifevantage’s EPS is below the industry average, signaling challenges in bottom-line performance with a current EPS of 0.15.

Debt Management: Lifevantage’s debt-to-equity ratio is below the industry average at 0.48, reflecting a lower dependency on debt financing and a more conservative financial approach.

Valuation Overview:

  • Price to Earnings (P/E) Ratio: A higher-than-average P/E ratio of 42.94 suggests caution, as the stock may be overvalued in the eyes of investors.

  • Price to Sales (P/S) Ratio: With a lower-than-average P/S ratio of 0.91, the stock presents an attractive valuation, potentially signaling a buying opportunity for investors interested in sales performance.

  • EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation & Amortization): Lifevantage’s EV/EBITDA ratio stands at 17.77, surpassing industry benchmarks. This places the company in a position with a higher-than-average market valuation.

Market Capitalization Analysis: Falling below industry benchmarks, the company’s market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.

Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.

Navigating the Impact of Insider Transactions on Investments

Insider transactions contribute to decision-making but should be supplemented by a comprehensive investment analysis.

In legal terms, an “insider” refers to any officer, director, or beneficial owner of more than ten percent of a company’s equity securities registered under Section 12 of the Securities Exchange Act of 1934. This can include executives in the c-suite and large hedge funds. These insiders are required to let the public know of their transactions via a Form 4 filing, which must be filed within two business days of the transaction.

When a company insider makes a new purchase, that is an indication that they expect the stock to rise.

Insider sells, on the other hand, can be made for a variety of reasons, and may not necessarily mean that the seller thinks the stock will go down.

A Closer Look at Important Transaction Codes

Examining transactions, investors often concentrate on those unfolding in the open market, meticulously detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C indicates the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.

Check Out The Full List Of Lifevantage’s Insider Trades.

Insider Buying Alert: Profit from C-Suite Moves

Benzinga Edge reveals every insider trade in real-time. Don’t miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. Click here for access.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Q3 2024 Financial Results

Reykjavík, Nov. 14, 2024 (GLOBE NEWSWIRE) — (“Amaroq” or the “Corporation” or the “Company”)

Q3 2024 Financial Results

TORONTO, ONTARIO – 14 November 2024 – Amaroq Minerals Ltd. (AIM, TSXV, NASDAQ Iceland: AMRQ), an independent mine development company with a substantial land package of gold and strategic mineral assets in Southern Greenland, presents its Q3 2024 financials.All dollar amounts are expressed in Canadian dollars unless otherwise noted.

A conference call for analysts and investors will be held tomorrow, 15 November 2024, at 08:30 GMT, details of which can be found further down in this announcement.

Eldur Olafsson, CEO of Amaroq, commented:

We are now on the cusp of achieving first gold at Nalunaq, a major milestone which will start initial cash flow ahead of a ramp-up to commercial production.

Over the third quarter we made significant headway at Nalunaq. Many of the major components of the processing plant were installed successfully and the development within the mine in the ‘Mountain Block’ enabled the first ore to be stockpiled for first gold production due this quarter. Our exploration programme at Nalunaq has furthered our understanding of the high-grade deposit with a drilling campaign on the Target Block expansion and the 75 Vein. Results on this and the first ore drives in Mountain Block are expected soon. We believe these results, also incorporating the last two years drill results, will provide for an updated Mineral Resource Estimate (MRE4) for Nalunaq early next year.

The exploration season was in full swing in Q3 and I’m very proud of what our exploration team has achieved this year. In addition to our on-going work at Nalunaq, we drilled the first two holes at Nanoq in our Gold portfolio, and across our strategic minerals portfolio we drilled [two] holes in Target North at Sava, undertook a three-drill rig campaign at Stendalen and drilled two scout holes at the historical Josva copper mine. We expect results from all of these campaigns over the next few months. This has laid a solid foundation for further Gold, Copper and Nickel exploration activities next year as we continue to unlock the full value of our portfolio in Greenland.

Q3 2024 Corporate Highlights

  • Amaroq group liquidity of $26.0 million consisting of cash balances, undrawn revolving credit overrun facility less trade payables ($62.2 million as of June 30, 2024).
  • Gold business working capital before convertible note liability and loan payable of $37.9 million that includes prepaid contractors on the Nalunaq project of $17.8 million as of September 30, 2024 ($50.5 million that includes prepaid contractors on the Nalunaq project of $19.6 million as of June 30, 2024)
  • The Gardaq Joint Venture that comprises the Strategic Minerals business has available liquidity of $8.3 million as of September 30, 2024 ($13.5 million as of June 30, 2024).
  • In July 2024, the Company agreed heads of terms, subject to final documentation, with Landsbankinn for US$35 million in three Revolving Credit Facilities, securing a substantial increase and extension to its current debt facilities. Final documentation is currently in progress.
  • Post period on 4 October, Amaroq entered into an agreement with the holders of its US$22.4 million convertible notes to convert the notes’ outstanding balance into new common shares. That measure serves to simplify Amaroq’s capital structure, reduces cash interest costs and increases future financial flexibility.
  • Amaroq continues to develop opportunities in Servicing and Hydro to enhance local procurement options and support the transition towards cleaner energy sources.

Q3 2024 Operational Highlights

  • Permitting: The Company is working with stakeholders on the Impact Benefit Agreement (IBA), which it aims to have in place by the end of the year.
  • Contracting and Procurement: Procurement of all key contract packages is 100% complete and all of the critical path items have been procured and have arrived on site already.
  • Engineering: Process plant detail design and engineering is 98% complete with all packages issued to the market and manufactured.
  • Construction: Plant pad earthworks and civil construction at Nalunaq is 100% complete. The plant building structural steel is complete and cladding is 98% complete. Mechanical installation of the crushing circuit is 68% complete and installation of the civil foundations for the retaining walls, stockpile reclaimer and stacker conveyor were completed in August 2024. The installation of the grinding and gold room section started in July 2024 and was completed post-period. The trackless mining machines and light vehicle workshop construction is complete and in operation. The grinding circuit structural and mechanical installations are complete and electrical installation is in progress. The reclaim feeder has been cleared for use. The thickener tank structure, mechanical and pipework is complete, and electrical installation is also complete. Cable tray installation is complete, and installation of power and control cabling has commenced and is 92% complete. A new wing was installed at the camp to accommodate up to 120 people on site.
  • Mining: Amaroq continues to focus on optimising mine development in the Mountain Block. The ramp has been completed to 742 level and ore development continued on 732 level. Both MineArc refuge stations have been commissioned, and the leaky feeder communication system was installed from 300 to the 720 level. Construction of the underground main heating system is progressing at the 300 level portal, and preparations have been made for heating of the ramp. The exhaust raise fan for Target Block was commissioned in preparation for the development of an exploration drift for diamond drilling and resource expansion, and another portal is planned on 742 level to support further development in Mountain Block. The Company is looking to improve its development rates and increase availability of mining fleet with its contractor Thyssen. Amaroq is also reviewing adding further mining equipment to optimise operations going forward. Finally, the Company has started employing its own mining team personnel.
  • Gold and Strategic Minerals Exploration: Post period, Amaroq announced the completion of the 2024 exploration programme, including over 8,600 metres of core drilling across the gold and strategic metals portfolio. Results for the programme are expected over the coming months.

Nalunaq Project KPIs

            Metric

            Q2 2024

            Q3 2024

            Change

Total hours worked

            103,680 hours

            129,516 hours

            +25%

Daily average of people working on site

            96 people

            107 people

            +12%

Ratio of Greenlandic personnel

            51%

            43%

            -8%

Outlook

  • Activities at Nalunaq remain on track to deliver first gold in Q4 2024.
  • Exploration results from gold, copper and nickel exploration expected at various intervals in Q4 2024 and Q1 2025.
  • Updated measured resource statement for Nalunaq Gold mine expected to be published in Q1 2025.

Exploration activities overview

Gold projects:

  • Nalunaq
    • All additional 75 Vein sampling from historical core housed at Nalunaq has been completed. A total of 2,895 meters of core drilling has been completed across the Target Block Extension zone to the west of the historical mining areas.
    • In parallel to this, a programme of surface samples along the outcropping Main Vein and 75 Vein to the west was completed with mountaineering specialists.
    • A Mineral Resource Estimate update for Nalunaq has been initiated with a Qualified Person’s site visit conducted by Mining Plus.
    • The Company is now awaiting the assay results before conducting a detailed review of the Target Block Extension zone and conducting further planning to address its 2025 exploration priorities.
  • Nanoq
    • A 130-meter scout drilling programme was completed at Nanoq across previous channel sampling results with core geologically assessed and sampled at Nalunaq. These cores will be geologically logged and sampled results will then be used to guide objectives for the 2025 season.
  • Nalunaq Satellite Targets
    • Following the discovery of an outcropping vein above historical high grade float results, a small surface sampling programme was completed at Eagle’s Nest with mountaineering specialists. The Company is now awaiting the results of the surface sampling, which will be used to help direct further work programmes.
    • Amaroq continues to assess the viability of other surrounding projects to become potential satellite feeds to Nalunaq.

Strategic Minerals:

  • Stendalen
    • A new surface geophysical programme was completed ahead of commencing the 2024 drilling programme.
    • A total of 4,733 meters of exploration drilling was completed at Stendalen with the aim of providing greater geological understanding to the mineralisation style and geometry. Demobilisation of equipment from Stendalen is underway to ensure operational readiness for 2025.
    • Assay and downhole geophysical results, once received, will be used in conjunction with the University of Leicester to assess the mineral system present and produce targeting models. Environmental samples will also be analysed to commence the environmental baseline data for the project.
  • Copper Belt (Sava/North Sava, Kobberminebugt)
    • The geological field team has completed a programme of mapping and sampling across the copper belt area, assessing both potential porphyry and magmatic Cu-Ni targets.
    • The team has been supplemented by external support from copper subject matter expert.
    • Following this work, a 212-meter scout drilling programme was completed at Josva copper skarn target within the Kobberminebugt licence as well as 501 meters of scout drilling within the epithermal copper/gold target at Target North within the Sava licence.
  • Nunarsuit
    • The Company is reviewing the geological maps and results received from prospecting across the Nunarsuit licence.

Details of conference call

A conference call for analysts and investors will be held tomorrow, 15 November, at 08:30am GMT BST, including a management presentation and Q&A session.

To join the meeting, please register at the below link:

https://us06web.zoom.us/webinar/register/WN_dhWLE36tQGabAf9MI_zcCA

Amaroq Financial Results

The following selected financial data is extracted from the Financial Statements for the six months ended June 30, 2024.

Financial Results

 

Nine months ended Sep 30

 

2024
$

2023
$

Exploration and evaluation expenses

(5,172,947)

(5,737,257)

Site development costs

General and administrative

(11,831,157)

(8,015,379)

Gain on loss of control of subsidiary

31,340,880

Share of 9-months loss of an equity-accounted joint arrangement

(6,698,550)

(5,021,231)

Unrealized gain on derivative liability

1,636,567

273,780

Net (loss) income and comprehensive (loss) income

(18,001,712)

13,425,594

Basic and diluted (loss) income per common share

(0.057)

0.05

Financial Position

 

As at Sep 30

As at June 30

 

2024
$

2024
$

Cash on hand

25,937,983

31,663,204

Total assets

199,102,439

177,950,773

Total current liabilities (before convertible notes liability and loan payable)

13,596,239

8,490,107

Total current liabilities (including convertible notes liability and loan payable)

76,516,905

41,932,965

Shareholders’ equity

121,963,411

135,365,745

Working capital – gold business (before convertible notes liability and loan payable)

37,937,316

50,734,743

Working capital – gold business (after convertible notes liability and loan payable)

(24,983,350)

17,291,885

Gold business liquidity (excluding $8.3 and $13.5M ring-fenced for strategic mineral exploration as of September 30, 2024 and June 30, 2024, respectively)

25,958,581

61,787,888

Enquiries:

Amaroq Minerals Ltd. 
Eldur Olafsson, Executive Director and CEO
eo@amaroqminerals.com 

Eddie Wyvill, Corporate Development
+44 (0)7713 126727
ew@amaroqminerals.com

Panmure Liberum (UK) Limited (Nominated Adviser and Corporate Broker)
Scott Mathieson
Kieron Hodgson
+44 (0) 20 7886 2500

Canaccord Genuity Limited (Corporate Broker)
James Asensio
Harry Rees
Tel: +44 (0) 20 7523 8000

Camarco (Financial PR)
Billy Clegg
Elfie Kent
Fergus Young
+44 (0) 20 3757 4980 

For Company updates:
Follow @Amaroq_minerals on X (Formerly known as Twitter)
Follow Amaroq Minerals Ltd on LinkedIn

Further Information: 

About Amaroq Minerals 

Amaroq Minerals’ principal business objectives are the identification, acquisition, exploration, and development of gold and strategic metal properties in South Greenland. The Company’s principal asset is a 100% interest in the past producing Nalunaq Gold mine which is due to go into production towards the end of 2024. The Company has a portfolio of gold and strategic metal assets in Southern Greenland covering the two known gold belts in the region as well as advanced exploration projects at Stendalen and the Sava Copper Belt exploring for Strategic metals such as Copper, Nickel, Rare Earths and other minerals. Amaroq Minerals is continued under the Business Corporations Act (Ontario) and wholly owns Nalunaq A/S, incorporated under the Greenland Public Companies Act.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Glossary

Ag

silver

Au

gold

Bt

Billion tonnes

Cu

copper

g

grams

g/t

grams per tonne

km

kilometers

Koz

thousand ounces

m

meters

Mo

molybdenum

MRE

Mineral Resource Estimate

MT

Magnetotelluric data

Nb

niobium

Ni

nickel

oz

ounces

REE

Rare Earth Elements

t

tonnes

Ti

Titanium

t/m3

tonne per cubic meter

U

uranium

USD/ozAu

US Dollar per ounce of gold

V

Vanadium

Zn

zinc

Inside Information

This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU) No. 596/2014 on Market Abuse (“UK MAR”), as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018, and Regulation (EU) No. 596/2014 on Market Abuse (“EU MAR”).

Qualified Person Statement

The technical information presented in this press release has been approved by James Gilbertson CGeol, VP Exploration for Amaroq Minerals and a Chartered Geologist with the Geological Society of London, and as such a Qualified Person as defined by NI 43-101.

Amaroq Minerals Ltd.

UNAUDITED CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS
For the three and nine months ended September 30, 2024

The attached financial statements have been prepared by Management of Amaroq Minerals Ltd. and have not been reviewed by the auditor

       
   

As at
September 30,

As at
December 31,

 

Notes

2024

2023

   

$

$

ASSETS

     

Current assets

     

Cash

 

25,937,983

21,014,633

Sales tax receivable

 

72,087

69,756

Prepaid expenses and others

 

17,812,986

18,681,568

Interest receivable

 

876,478

Inventory

 

6,834,021

680,358

Total current assets

 

51,533,555

40,446,315

Non-current assets

     

Deposit

 

177,944

27,944

Escrow account for environmental rehabilitation

 

6,872,073

598,939

Financial Asset – Related Party

3,13

5,762,187

3,521,938

Investment in equity accounted joint arrangement

3

16,794,261

23,492,811

Mineral properties

4

48,683

48,821

Right of use asset

7

652,190

574,856

Capital assets

5

117,261,546

38,241,559

Total non-current assets

 

147,568,884

66,506,868

TOTAL ASSETS

 

199,102,439

106,953,183

 

LIABILITIES AND EQUITY

     

Current liabilities

     

Accounts payable and accrued liabilities

 

13,479,402

6,273,979

Convertible notes

6

38,395,349

35,743,127

Loan payable

6.1

24,525,317

Lease liabilities – current portion

7

116,837

80,206

Total current liabilities

 

76,516,905

42,097,312

Non-current liabilities

     

Lease liabilities

7

622,123

577,234

Total non-current liabilities

 

622,123

577,234

Total liabilities

 

77,139,028

42,674,546

 

Equity

     

Capital stock

8

207,202,359

132,117,971

Contributed surplus

 

7,327,666

6,725,568

Accumulated other comprehensive loss

 

(36,772)

(36,772)

Deficit

 

(92,529,842)

(74,528,130)

Total equity

 

121,963,411

64,278,637

TOTAL LIABILITIES AND EQUITY

 

199,102,439

106,953,183

       

Subsequent events

16

   

The accompanying notes are an integral part of these unaudited condensed interim consolidated financial statements.

   

Three months
ended September 30,

Nine months
ended September 30,

 

Notes

2024

2023

2024

2023

   

$

$

$

$

           

Expenses

         

Exploration and evaluation expenses

10

(4,424,907)

(2,277,540)

(5,172,947)

(5,737,257)

Site development costs

 

1,825,564

General and administrative

11

(3,536,240)

(2,632,041)

(11,831,157)

(8,015,379)

Loss on disposal of capital assets

5

(149,917)

(149,917)

(37,791)

Foreign exchange gain (loss)

 

1,040,420

(83,882)

1,475,432

(58,707)

Operating loss

 

(7,070,644)

(3,167,899)

(15,678,589)

(13,849,134)

 

Other income (expenses)

         

Interest income

 

901,831

141,443

943,023

613,031

Gardaq management income and allocated cost

 

608,392

601,461

1,823,286

1,108,101

Gain on loss of control of subsidiary

3

31,340,880

Share of net loss of joint arrangement

3

(4,788,733)

(3,381,749)

(6,698,550)

(5,021,231)

Unrealized gain (loss) on derivative liability

6

(3,655,048)

273,780

1,636,567

273,780

Finance costs

12

(9,317)

(1,022,258)

(27,449)

(1,039,833)

           

Net income (loss) and comprehensive income (loss)

 

(14,013,519)

(6,555,222)

(18,001,712)

13,425,594

           
           
           
           

Weighted average number of common shares outstanding – basic

 

327,418,727

263,579,331

314,985,260

263,356,034

Weighted average number of common shares outstanding – diluted

 

327,418,727

306,335,274

314,985,260

306,111,977

Basic earnings (loss) per share

14

(0.043)

(0.02)

(0.057)

0.05

Diluted earnings (loss) per common share

14

(0.043)

(0.02)

(0.057)

0.04

Effect of dilution

 

0.01

Share options

 

7,261,353

9,126,875

7,261,353

9,126,875

Restricted shares

 

6,659,409

6,659,409

The accompanying notes are an integral part of these unaudited condensed interim consolidated financial statements.

Amaroq Minerals Ltd.
Consolidated Statements of Changes in Equity
(Unaudited, in Canadian Dollars)

 

 

 

 

Notes

Number of common shares outstanding

Capital Stock

Contributed surplus

Accumulated other comprehensive
loss

Deficit

 

Total Equity

     

$

$

$

$

$

Balance at January 1, 2023

 

263,073,022

131,708,387

5,250,865

(36,772)

(73,694,581)

63,227,899

Net income and comprehensive income

 

13,425,594

13,425,594

Options exercised, net

 

597,029

409,584

(433,600)

(24,016)

Stock-based compensation

9

1,353,042

1,353,042

Balance at September 30, 2023

 

263,670,051

132,117,971

6,170,307

(36,772)

(60,268,987)

77,982,519

               

Balance at January 1, 2024

 

263,670,051

132,117,971

6,725,568

(36,772)

(74,528,130)

64,278,637

Net loss and comprehensive loss

 

(18,001,712)

(18,001,712)

Shares issued under a fundraising

8

62,724,758

75,574,600

75,574,600

Shares issuance costs

8

(1,218,285)

(1,218,285)

Options exercised – net

9.1

1,023,918

728,073

(745,500)

(17,427)

Stock-based compensation

9

1,347,598

1,347,598

Balance at September 30, 2024

 

327,418,727

207,202,359

7,327,666

(36,772)

(92,529,842)

121,963,411

The accompanying notes are an integral part of these unaudited condensed interim consolidated financial statements.

     
 

 

Notes

Nine months ended September 30,

   

2024

2023

   

$

$

Operating activities

     

Net (loss) income for the period

 

(18,001,712)

13,425,594

Adjustments for:

     

Depreciation

5

603,135

525,518

Amortisation of ROU asset

7

83,704

59,991

Stock-based compensation

9

1,347,598

1,353,042

Gain on loss of control of subsidiary

3

(31,340,880)

Unrealized gain on derivative liability

6

(1,636,567)

(273,780)

Embedded derivate related transaction costs

 

641,526

Loss on disposal of capital assets

 

149,916

37,791

Share of net losses of joint arrangement

3

6,698,550

5,021,231

Gardaq management income and allocated cost

3,13

(1,823,286)

(1,108,101)

Interest income

 

(943,023)

(613,031)

Other expenses

 

(17,427)

Foreign exchange

 

(1,624,654)

(1,114,277)

Finance costs

 

27,449

   

(15,136,317)

(13,385,376)

Changes in non-cash working capital items:

     

Sales tax receivable

 

(2,331)

30,178

Due from related party

3,13

(388,400)

(52,304)

Prepaid expenses and others

 

(5,154,320)

(5,808,291)

Accounts payable and accrued liabilities

 

7,203,774

1,179,419

   

1,658,723

(4,650,998)

Cash flow used in operating activities

 

(13,477,594)

(18,036,374)

 

Investing activities

     

Transfer to escrow account for environmental rehabilitation

 

(6,044,556)

(165,946)

Construction in progress and acquisition of capital assets

5

(75,508,967)

(9,409,183)

Prepayment for acquisition of ROU asset

 

(5,825)

Deposit

 

(150,000)

Cash flow used in investing activities

 

(81,709,348)

(9,575,129)

 

Financing activities

     

Proceeds from issuance of shares

8

75,574,600

Proceeds from convertible notes, net of issue costs

6

29,427,152

Proceeds from loan, net of transaction cost

6

24,394,364

Shares issuance costs

8

(1,218,285)

Lease payments

7

(101,143)

(53,583)

Interest received

 

66,545

613,031

Cash flow from financing activities

 

98,716,081

29,986,600

Net change in cash before effects of exchange rate changes on cash during the period

 

3,529,139

2,375,097

Effects of exchange rate changes on cash

 

1,394,211

1,143,288

Net change in cash during the period

 

4,923,350

3,518,385

Cash, beginning of period

 

21,014,633

50,137,569

Cash, end of period

 

25,937,983

53,655,954

Supplemental cash flow information

     

Borrowing costs capitalised to capital assets

5

4,263,933

ROU assets acquired through lease

7

155,214

Shares issued as a result of options exercised – net

9.1

728,073

The accompanying notes are an integral part of these unaudited condensed interim consolidated financial statements.

  1.    NATURE OF OPERATIONS, BASIS OF PRESENTATION

Amaroq Minerals Ltd. (the “Corporation”) was incorporated on February 22, 2017, under the Canada Business Corporations Act. As of June 19, 2024, the Corporation completed its continuance from the Canada Business Corporations Act into the Province of Ontario under the Business Corporations Act (Ontario). The Corporation’s head office is situated at 100 King Street West, Suite 3400, First Canadian Place, Toronto, Ontario, M5X 1A4, Canada. The Corporation operates in one industry segment, being the acquisition, exploration and development of mineral properties. It owns interests in properties located in Greenland. The Corporation’s financial year ends on December 31. Since July 2017, the Corporation’s shares are listed on the TSX Venture Exchange (the “TSX-V”). Since July 2020, the Corporation’s shares are also listed on the AIM market of the London Stock Exchange (“AIM”) and from November 1, 2022, on Nasdaq First North Growth Market Iceland which were transferred on September 21, 2023 on Nasdaq Main Market Iceland (“Nasdaq”) under the AMRQ ticker.

These unaudited condensed interim consolidated financial statements for the nine months ended September 30, 2024 (“Financial Statements”) were approved by the Board of Directors on November 14, 2024.

1.1    Basis of presentation and consolidation

The Financial Statements include the accounts of the Corporation and those of its 100% owned subsidiary Nalunaq A/S, company incorporated under the Greenland Public Companies Act. The Financial Statements also include the Corporation’s 51% equity share of Gardaq A/S, a joint venture with GCAM LP (Note 3).

The Financial Statements have been prepared in accordance with International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”) including International Accounting Standard (“IAS”) 34, Interim Financial Reporting. The Financial Statements have been prepared under the historical cost convention.

The Financial Statements should be read in conjunction with the audited annual financial statements for the year ended December 31, 2023, which have been prepared in accordance with IFRS as issued by the IASB. The accounting policies, methods of computation and presentation applied in these Financial Statements are consistent with those of the previous financial year ended December 31, 2023.

  2.    CRITICAL ACCOUNTING JUDGMENTS AND ASSUMPTIONS

The preparation of the Financial Statements requires Management to make judgments and form assumptions that affect the reported amounts of assets and liabilities at the date of the Financial Statements and reported amounts of expenses during the reporting period. On an ongoing basis, Management evaluates its judgments in relation to assets, liabilities and expenses. Management uses past experience and various other factors it believes to be reasonable under the given circumstances as the basis for its judgments. Actual outcomes may differ from these estimates under different assumptions and conditions.

In preparing the Financial Statements, the significant judgements made by Management in applying the Corporation accounting policies and the key sources of estimation uncertainty were the same as those that applied to the Corporation’s audited annual financial statements for the year ended December 31, 2023.

3.        INVESTMENT IN AN ASSOCIATE OR JOINT VENTURE CORPORATION

 

As at
September 30,
2024

As at
    December 31,
2023

 

$

$

Balance at beginning of period

23,492,811

        Original investment in Gardaq ApS

7,422

        Transfer of non-gold strategic minerals licences at cost

36,896

        Investment at conversion of Gardaq ApS to Gardaq A/S

55,344

        Gain on FV recognition of equity accounted investment in joint venture

31,285,536

        Share of joint venture’s net losses

(6,698,550)

(7,892,387)

Balance at end of period

16,794,261

23,492,811

        Original investment in Gardaq ApS

7,422

7,422

        Transfer of non-gold strategic minerals licences at cost

36,896

36,896

        Investment at conversion of Gardaq ApS to Gardaq A/S

55,344

55,344

        Gain on FV recognition of equity accounted investment in joint venture

31,285,536

31,285,536

        Investment retained at fair value- 51% share

31,385,198

31,385,198

Share of joint venture’s cumulative net losses

(14,590,937)

(7,892,387)

Balance at end of period

16,794,261

23,492,811

The following tables summarize the unaudited financial information of Gardaq A/S.

 

As at
September 30,
2024

As at
   December 31,
2023

 

$

$

Cash and cash equivalent

8,325,045

18,377,850

Prepaid expenses and other

560,579

351,752

Total current assets

8,885,624

18,729,602

Mineral property

117,576

92,239

Total assets

9,003,200

18,821,841

Accounts payable and accrued liabilities

1,603,757

528,235

Financial liability – related party

5,762,187

3,521,938

Total liabilities

7,365,944

4,050,173

Capital stock

30,246,937

30,246,937

Deficit

(28,609,681)

(15,475,269)

Total equity

1,637,256

14,771,668

Total liabilities and equity

9,003,200

18,821,841

3.        INVESTMENT IN AN ASSOCIATE OR JOINT VENTURE CORPORATION (CONT’d)

 

As at
September 30,
2024

As at
September 30,
2023

 

$

$

Exploration and Evaluation expenses

12,144,276

8,565,658

Interest expense (income)

(5,985)

Foreign exchange loss (gain)

(858,925)

171,792

Operating loss

11,279,366

8,737,450

Other expenses

1,855,047

1,108,101

Net loss and comprehensive loss

13,134,413

9,845,551

3.1 Financial Asset – Related Party

Subject to a Subscription and Shareholder Agreement dated 13 April 2023, the Corporation undertakes to subscribe to two ordinary shares in Gardaq (the “Amaroq shares”) at a subscription price of GBP 5,000,000 no later than 10 business days after the third anniversary of the completion of the subscription agreement.

Amaroq’s subscription will be completed by the conversion of Gardaq’s related party balance into equity shares. Gardaq’s related party payable balance consists of overhead, management, general and administrative expenses payable to the Corporation. In the event that the related party payable balance is less than GBP 5,000,000, the Corporation shall, no later than 10 business days after the third anniversary of Completion:

(a)   subscribe to one Amaroq share by conversion of the amount payable to the Corporation,
(b)   subscribe to one Amaroq share at a subscription price equal to GBP 5,000,000 less the amount payable to the Corporation

In the event that the amount payable to the Corporation exceeds GBP 5,000,000, the Corporation shall subscribe to the Amaroq shares at a subscription price equal to GBP 5,000,000 by conversion of GBP 5,000,000 of the amount due from Gardaq. Gardaq shall not be liable to repay any of the balance payable to the Corporation that exceeds GBP 5,000,000 (equivalent to CAD 9,048,791 as at 30 September 2024). See note 13.1.

During the nine-month period ended 30 September 2024, the Corporation determined that the financial asset should be reclassified to the non-current asset category since the amount will be settled during April 2026. As a result, an amount of $5,762,187 has been reclassified to non-current assets as at 30 September 2024 ($3,521,938 reclassified as at 31 December 2023).

  4.    MINERAL PROPERTIES

 

As at December 31,
2023

 

 

Transfer

As at September 30,
2024

 

$

$

$

Nalunaq – Au

1

1

Tartoq – Au

18,431

18,431

Vagar – Au

11,103

11,103

Nuna Nutaaq – Au

6,076

6,076

Anoritooq – Au

6,389

6,389

Siku – Au

6,821

(138)

6,683

Total mineral properties

48,821

(138)

48,683

  4.   MINERAL PROPERTIES (CONT’d)

 

As at December 31,
2022

 

 

Transfers

As at September 30,
2023

 

$

$

$

Nalunaq – Au

1

1

Tartoq – Au

18,431

18,431

Vagar – Au

11,103

11,103

Nuna Nutaaq – Au

6,076

6,076

Anoritooq – Au

6,389

6,389

Siku – Au

6,821

6,821

Naalagaaffiup Portornga – Strategic Minerals

6,334

(6,334)

Saarloq – Strategic Minerals

7,348

(7,348)

Sava – Strategic Minerals

6,562

(6,562)

Kobberminebugt – Strategic Minerals

6,840

(6,840)

Stendalen – Strategic Minerals

4,837

(4,837)

North Sava – Strategic Minerals

4,837

(4,837)

Total mineral properties

85,579

(36,758)

48,821

  5.   CAPITAL ASSETS

 

Field equipment and
infrastructure

 

Vehicles and rolling stock

 

Equipment (including software)

 

Construction in progress

 

 

 

Total

 

$

$

$

$

$

 

Nine months ended September 30, 2024

         

Opening net book value

1,537,379

3,312,118

108,822

33,283,240

38,241,559

Additions

1,941,750

138

77,831,150

79,773,038

Disposals

(149,916)

(149,916)

Depreciation

(148,780)

(407,563)

(46,792)

(603,135)

 

Closing net book value

1,388,599

4,696,389

62,168

111,114,390

117,261,546

 

Field equipment and
infrastructure

 

Vehicles and rolling stock

 

Equipment (including software)

 

Construction in progress

 

 

 

Total

 

$

$

$

$

$

 

As at September 30, 2024

         

Cost

2,351,042

6,197,074

232,231

111,114,390

119,894,737

Accumulated depreciation

(962,443)

(1,500,685)

(170,063)

(2,633,191)

 

Closing net book value

1,388,599

4,696,389

62,168

111,114,390

117,261,546

  5.   CAPITAL ASSETS (CONT’d)

 

Field equipment and
infrastructure

Vehicles and rolling stock

Equipment (including software)

Construction In progress

Total

 

$

$

$

$

$

 

December 31, 2023

         

Opening net book value

1,735,752

3,742,384

216,385

7,522,085

13,216,606

Additions

25,761,155

25,761,155

Disposals

(80,983)

(80,983)

Adjustment

43,054

43,054

Depreciation

(198,373)

(430,266)

(69,634)

(698,273)

Closing net book value

1,537,379

3,312,118

108,822

33,283,240

38,241,559

 

Field equipment and
infrastructure

Vehicles and rolling stock

Equipment (including software)

Construction In progress

Total

 

$

$

$

$

$

As at December 31, 2023

         

Cost

2,351,041

4,466,971

232,231

33,283,240

40,333,483

Accumulated depreciation

(813,662)

(1,154,853)

(123,409)

(2,091,924)

Closing net book value

1,537,379

3,312,118

108,822

33,283,240

38,241,559

Depreciation of capital assets related to exploration and evaluation properties is being recorded in exploration and evaluation expenses in the consolidated statement of comprehensive loss, under depreciation. Depreciation of $556,632 ($478,519 for the nine months ended September 30, 2023) was expensed as exploration and evaluation expenses during the nine months ended September 30, 2024.

As at September 30, 2024, the Corporation had capital commitments, of $25,532,115. These commitments relate to the development of Nalunaq Project, rehabilitation of the Nalunaq mine, construction of processing plant, purchases of mobile equipment and establishment of surface infrastructure.

During the first nine months of 2024 the Corporation capitalised borrowing costs of $4,263,933 to construction in progress, which are included in additions.

  6.   CONVERTIBLE NOTES AND LOAN PAYABLE

CONVERTIBLE NOTES

Convertible notes loan

Embedded Derivatives at FVTPL

Total

 

$

$

$

Balance as at December 31, 2023

11,763,053

23,980,074

35,743,127

Accretion of discount

2,910,769

2,910,769

Accrued interest

1,142,212

1,142,212

Fair value change

(1,636,567)

(1,636,567)

Foreign exchange loss

235,808

235,808

Balance as at September 30, 2024

16,051,842

22,343,507

38,395,349

Non-current portion

Current portion

16,051,842

22,343,507

38,395,349

6. CONVERTIBLE NOTES AND LOAN PAYABLE (CONT’d)

CONVERTIBLE NOTES

Convertible notes loan

Embedded Derivatives at FVTPL

Total

 

$

$

$

Balance as at December 31, 2022

Gross proceeds from issue

30,431,180

30,431,180

Embedded derivative component

(19,443,663)

19,443,663

Transaction costs

(362,502)

(362,502)

Accretion of discount

949,062

949,062

Accrued interest

508,576

508,576

Fair value change

4,536,411

4,536,411

Foreign exchange gain

(319,600)

(319,600)

Balance as at December 31, 2023

11,763,053

23,980,074

35,743,127

Non-current portion

Current portion

11,763,053

23,980,074

35,743,127

LOAN PAYABLE

As at
September 30,
2024

As at
December 31,
2023

 

$

$

Balance as at December 31, 2023

Gross proceeds from issue

25,087,636

Transaction costs

(693,272)

Accretion of discount

32,973

Accrued interest

177,979

Foreign exchange gain

(79,999)

Balance as at September 30, 2023

24,525,317

Non-current portion

Current portion

24,525,317

6.1 Revolving Credit Facility

A $25 million (US$18.5 million) Revolving Credit Facility (“RCF”) was entered into with Landsbankinn hf. and Fossar Investment Bank on September 1, 2023, with a two-year term expiring on September 1, 2025 and priced at the Secured Overnight Financing Rate (“SOFR”) plus 950bps. Interest is capitalized and payable at the end of the term.

The RCF is denominated in US Dollars and the SOFR interest rate is determined with reference to the CME Term SOFR Rates published by CME Group Inc. The RCF carries (i) a commitment fee of 0.40% per annum calculated on the undrawn facility amount and (ii) an arrangement fee of 2.00% on the facility amount where 1.5% has been paid on the closing date of the facility and 0.50% was paid at the first draw down. The facility is not convertible into any securities of the Corporation.

The facility is secured by (i) a bank account pledge from the Corporation and Nalunaq A/S, (ii) share pledges over all current and future acquired shares in Nalunaq A/S and Gardaq A/S held by the Corporation pursuant to the terms of share pledge agreements, (iii) a proceeds loan assignment agreement, (iv) a pledge agreement in respect of owner’s mortgage deeds and (v) a licence transfer agreement. During September 2024, the Corporation has drawn on this facility and the loan payable amount as of September 30, 2024, is $25,069,002.

This facility will be replaced by the new revolving credit facilities that are expected to be finalized subsequent to the interim financial reporting date (see note 6.4).

6.    CONVERTIBLE NOTES AND LOAN PAYABLE (CONT’d)

6.2 Convertible notes

Convertible notes represent $30.4 million (US$22.4 million) notes issued to ECAM LP (US$16 million), JLE Property Ltd. (US$4 million) and Livermore Partners LLC (US$2.4 million) on September 1, 2023 with a four-year term and a fixed interest rate of 5%. The conversion price of $0.90 per common share is the closing Canadian market price of the Amaroq shares on the day, prior to the closing day of the Debt Financing.

The convertible notes are denominated in US Dollars and will mature on September 30, 2027, being the date that is four years from the convertible note offering closing date. The principal amount of the convertible notes will be convertible, in whole or in part, at any time from one month after issuance into common shares of the Corporation (“Common Shares”) at a conversion price of $0.90 (£0.525) per Common Share for a total of up to 33,629,068 Common Shares. The Corporation may repay the convertible notes and accrued interest at any time, in cash, subject to providing 30 days’ notice to the relevant noteholders, with such noteholders having the option to convert such convertible notes into Common Shares at the conversion price up to 5 days prior to the redemption date. If the Corporation chooses to redeem some but not all of the outstanding convertible notes, the Corporation shall redeem a pro rata share of each noteholder’s holding of convertible notes. The Corporation shall pay a commitment fee to the holders of the convertible notes of, in aggregate, $5,511,293 (US$4,484,032), which shall be paid pro rata to each noteholder’s holding of convertible notes. The commitment fee is payable on the earlier of (a) the date falling 20 business days after all amounts outstanding under the Bank Revolving Credit Facility have been repaid in full, but no earlier than the date that is 24 months after the date of issuance of the notes; and (b) the date falling 30 (thirty) months after the date of the subscription agreement in respect of the notes, irrespective of whether or not notes have converted at that date or been repaid.

The convertible notes will be secured by (i) bank account pledge agreements from the Corporation and Nalunaq A/S, (ii) share pledges over all current and future acquired shares in Nalunaq A/S and Gardaq A/S held by the Corporation pursuant to the terms of share pledge agreements, (iii) a proceeds loan assignment agreement, (iv) a pledge agreement in respect of owner’s mortgage deeds and (v) a licence transfer agreement.

The convertible notes represent hybrid financial instruments with embedded derivatives requiring separation. The debt host portion (the “Host”) of the instrument is initially recognised at fair value and subsequently measured at amortized cost, whereas the aggregate conversion and repayment options (the “Embedded Derivatives”) are classified at fair value through profit and loss (FVTPL).

The fair value of the convertible notes at inception was recognized at $30.4 million (US$22.4 million) and $19.4 million (US$14.3 million) embedded derivative component was isolated and determined using a Black Scholes valuation model which required the use of significant unobservable inputs. As of September 30, 2024, the Corporation identified the fair value of embedded derivative associated with the early conversion option to be $22.3 million ($24.0 million as of December 31, 2023). The change in fair value of embedded derivative in the period from January 1, 2024 to September 30, 2024 has been recognized in the consolidated statement of comprehensive loss. The Host liability component at inception, before deducting transaction costs, was recognized to be the residual amount of $10.9 million (US$8.1 million) which is subsequently measured at amortized cost. Transaction costs incurred on the issuance of the convertible note amounted to $1,004,030, of which $362,502 was allocated to, and deducted from, the host liability component, and $641,528 was allocated to the embedded derivative component and charged to profit and loss.

Amendments and conversion of these convertible notes were concluded subsequently to the interim financial reporting date (see note 6.4).

6.    CONVERTIBLE NOTES AND LOAN PAYABLE (CONT’D)

6.3 Cost Overrun Facility

$13.5 million (US$10 million) Revolving Cost Overrun Facility was entered into with JLE Property Ltd. on September 1, 2023, on the same terms as the Bank Revolving Credit Facility.

The Overrun Facility is denominated in US Dollars with a two-year term, expiring on September 1, 2025, and will bear interest at the CME Term SOFR Rates by CME Group Inc. and have a margin of 9.5% per annum. The Overrun Facility carries a stand-by fee of 2.5% on the amount of committed funds. The Overrun Facility is not convertible into any securities of the Corporation.

The Overrun Facility will be secured by (i) bank account pledge agreements from the Corporation and Nalunaq A/S, (ii) share pledges over all current and future acquired shares in Nalunaq A/S and Gardaq A/S held by the Corporation pursuant to the terms of share pledge agreements, (iii) a proceeds loan assignment agreement, (iv) a pledge agreement in respect of owner’s mortgage deeds and (v) a licence transfer agreement. The Corporation has not yet drawn on this facility.

This facility will be replaced by the new revolving credit facilities that are expected to be finalized subsequent to the interim financial reporting date (see note 6.4).

6.4 US$35 million Revolving Credit Facility Heads of Terms

On July 2, 2024, the Corporation announced that it agreed a Head of Terms, subject to final approval and documentation, with Landsbankinn for US$35 million in three Revolving Credit Facilities, securing a substantial increase and extension to its existing debt facilities.

  • The financing package will replace the existing credit and cost overrun facilities, simplifying the structure of the debt package and increasing financial flexibility and liquidity for the Corporation.
  • Amaroq has signed term sheets for a US$35 million debt financing package with Landsbankinn consisting of:
    • US$28.5 million facility with a margin of 9.5% per annum, reducing to 7.5% once the full amount has been drawn and the Corporation’s cumulative EBITDA over a three-month period exceeds CAD 6 million. This facility will replace the Corporation’s existing revolving credit and cost overrun facilities entered into on September 1, 2023. US$18.5 million of the facility is to be used towards the completion of the Nalunaq development with the balance available for general corporate purposes.
    • US$6.5 million facility with a margin of 7.5% per annum, available for general corporate purposes once all other facilities have been fully drawn.
    • The new facilities will have a 1.5% arrangement fee, a 0.4% commitment fee on unutilised amounts, and an expected maturity date of October 1, 2026.
    • The new facilities will be subject to certain ongoing covenant tests, further detail of which will be provided on closing of definitive documentation.
  • Amaroq will finalise the new facilities’ legally binding documentation and expects to be in a position to sign binding documents before the end of the year. The Corporation’s currently undrawn US$10.0 million debt facilities will remain in place until this time.

     7.    LEASE LIABILITIES

 

As at
September 30,
2024

As at
December 31,
2023

 

$

$

Balance beginning

657,440

729,237

Lease additions

155,214

Lease payment

(101,143)

(105,894)

Interest

27,449

34,097

Balance ending

738,960

657,440

Non-current portion – lease liabilities

(622,123)

      (577,234)

Current portion – lease liabilities

116,837

80,206

The Corporation has two leases for its offices. In October 2020, the Corporation started a lease for five years and five months including five free rent months during this period. The monthly rent is $8,825 until March 2024 and $9,070 for the balance of the lease. The Corporation has the option to renew the lease for an additional five-year period at $9,070 monthly rent indexed annually to the increase of the consumer price index of the previous year for the Montreal area. In March 2024, the Corporation started a new lease for a two-year term with the option to extend for two more years. The monthly rent is $5,825 until March 2025 after which the monthly rent may increase as per the lease terms.

7.1         Right of use asset

 

As at

As at

 

September 30,

December 31,

 

2024

2023

 

$

$

Opening net book value

574,856

655,063

Additions

161,038

Amortisation

(83,704)

(80,207)

Closing net book value

652,190

574,856

     

Cost

997,238

836,200

Accumulated amortisation

(345,048)

(261,344)

Closing net book value

652,190

574,856

8.   SHARE CAPITAL

On February 23, 2024, the Corporation successfully completed its oversubscribed fundraising which resulted in a total of 62,724,758 new common shares being placed with new and existing institutional investors at a placing price of 74 pence (CAD $1.25 at the closing exchange rate on 9 February 2024). The placing price represents a 5.7% premium to the closing share price on 9 February 2024 on the AIM exchange. The fundraising consisted of:

  • A placing of new common shares with new and existing institutional investors at the placing price (the “UK Placing”). Stifel Nicolaus Europe Limited acted as the sole bookrunner and broker on the UK Placing.
  • A placing of new depository receipts representing new common shares with new and existing investors at the placing price (the “Icelandic Placing”). Landsbankinn hf. and Fossar fjarfestingarbanki hf. acted as joint bookrunners on the Icelandic Placing and Landsbankinn hf. acted as underwriter.
  • A private placement of new common shares by certain existing institutional investors and a director of the Corporation at the placing price (the “Canadian Subscription”). The Director subscribed to approximately CAD $3.4 million (equivalent to GBP 2.0 million) in the fundraising.

As a result of the subscription, net proceeds of approximately GBP 44 million (CAD 75.6 million) have been raised, exceeding the initial targeted amount of GBP 30 million. The shares subscribed to were credited as fully paid and rank pari passu in all respects with the existing common shares of the Corporation.

     9.   STOCK-BASED COMPENSATION

        9.1 Stock options

An incentive stock option plan (the “Plan”) was approved initially in 2017 and renewed by shareholders on June 14, 2024. The Plan is a “rolling” plan whereby a maximum of 10% of the issued shares at the time of the grant are reserved for issue under the Plan to executive officers, directors, employees and consultants. The Board of directors attributes that the stock options and the exercise price of the options shall not be less than the closing price on the last trading day, preceding the grant date. The options have a maximum term of ten years. Options granted pursuant to the Plan shall vest and become exercisable at such time or times as may be determined by the Board, except options granted to consultants providing investor relations activities shall vest in stages over a 12-month period with a maximum of one-quarter of the options vesting in any three-month period. The Corporation has no legal or constructive obligation to repurchase or settle the options in cash.

On May 14, 2024, and June 3, 2024, the Corporation granted its employees 22,988 stock options with an exercise price ranging from $1.30 to $1.31 per share. The stock options vested 100% at the grant date. The options were granted at an exercise price equal to the closing market price of the shares the day prior to the grant. Total stock-based compensation costs amounted to $18,163 for an estimated fair value of $0.72 per share.

On January 5, 2024, a former director of the Corporation exercised his options. As a result, 150,000 options were exercised which resulted in the former director receiving 60,637 shares net of applicable withholdings. On May 23, 2024, the former Chief Financial Officer (“CFO”) of the Corporation exercised his options. As a result, 1,800,000 options were exercised which resulted in the former CFO receiving 963,281 shares net of applicable withholdings.On October 9, 2024, an employee of the Corporation exercised his options. As a result, 31,278 options were exercised which resulted in the employee receiving 11,090 shares net of applicable withholdings   

9. STOCK-BASED COMPENSATION (CONT’d)

Changes in stock options are as follows:

 

Nine months ended September 30, 2024

December 31, 2023

 

Number of options

Weighted average exercise price

Number of options

Weighted average exercise price

   

$

 

$

Balance, beginning

9,188,365

0.59

10,717,395

0.57

Granted

22,988

1.30

80,970

1.01

Exercised

(1,950,000)

0.60

(1,610,000)

0.46

Balance, end

7,261,353

0.59

9,188,365

0.59

Balance, end exercisable

7,261,353

0.59

9,188,365

0.59

Stock options outstanding and exercisable as at September 30, 2024 are as follows:

Number of options outstanding

Number of options exercisable

Exercise price

 

Expiry date

   

$

 

1,670,000

1,670,000

0.38

December 31, 2025

100,000

100,000

0.50

September 13, 2026

1,245,000

1,245,000

0.70

December 31, 2026

2,700,000

2,700,000

0.60

January 17, 2027

73,333

73,333

0.75

April 20, 2027

39,062

39,062

0.64

July 14, 2027

1,330,000

1,330,000

0.70

December 30, 2027

19,480

19,480

0.77

July 24, 2028

61,490

61,490

1.09

December 20, 2028

11,538

11,538

1.30

May 14, 2029

11,450

11,450

1.31

June 3, 2029

7,261,353

7,261,353

   

        9.2 Restricted Share Unit

9.2.1 Description

Conditional awards were made in 2022 that give participants the opportunity to earn restricted share unit awards under the Corporation’s Restricted Share Unit Plan (“RSU Plan”) subject to the generation of shareholder value over a four-year performance period.

The awards are designed to align the interests of the Corporation’s employees and shareholders, by incentivising the delivery of exceptional shareholder returns over the long-term. Participants receive a 10% share of a pool which is defined by the total shareholder value created above a 10% per annum compound hurdle.

The awards comprise three tranches, based on performance measured from January 1, 2022, to the following three measurement dates:

  • First Measurement Date: December 31, 2023;
  • Second Measurement Date: December 31, 2024; and
  • Third Measurement Date: December 31, 2025.

9. STOCK-BASED COMPENSATION (CONT’d)

Restricted share unit awards granted under the RSU Plan as a result of achievement of the total shareholder return performance conditions are subject to continued service, with vesting as follows:

  • Awards granted after the First Measurement Date – 50% vest after one year, 50% vest after three years.
  • Awards granted after the Second Measurement Date – 50% vest after one year, 50% vest after two years.
  • Awards granted after the Third Measurement Date – 100% vest after one year.

The maximum term of the awards is therefore four years from grant.

The Corporation’s starting market capitalization is based on a fixed share price of $0.552. Value created by share price growth and dividends paid at each measurement date will be calculated with reference to the average closing share price over the three months ending on that date.

  • After December 31, 2023, 100% of the pool value at the First Measurement Date is delivered as restricted share units under the RSU Plan, subject to the maximum number of shares that can be allotted not being exceeded.
  • After December 31, 2024, the pool value at the Second Measurement Date is reduced by the pool value from the First Measurement Date (increased in line with share price movements between the First and Second Measurement Dates). 100% of the remaining pool value, if any, is delivered as restricted share units under the RSU Plan.
  • After December 31, 2025, the pool value at the Third Measurement Date is reduced by the pool value from the Second Measurement Date (increased in line with share price movements between the Second and Third Measurement Dates), and then further reduced by the pool value from the First Measurement Date (increased in line with share price movements between the First Measurement Date and the Third Measurement Date). 100% of the remaining pool value, if any, is delivered as restricted share units under the RSU Plan.

9.2.2 RSU Plan Amendment

The RSU Plan was amended by a shareholders General Meeting on June 15, 2023. As a result of the amendment the number of shares that could be issued under the RSU Plan to satisfy the conditional awards and other share awards was increased from 10% of a fixed share capital amount of 177,098,740 shares to 10% of share capital at the time of award, amounting to 10% of 263,073,022 shares, reduced by the number of outstanding options at each calculation date. As a result, an additional expense based on the difference between the fair value of the conditional awards before and after the modification will be recognised over the service period. The incremental fair value was determined and incorporated info the valuation in 9.2.4.

9. STOCK-BASED COMPENSATION (CONT’d)

9.2.3 New Conditional Award under RSU Plan

On October 13, 2023, Amaroq made an award (the “Award”) under the RSU Plan as detailed below. The Award consists of a conditional right to receive value if the future performance targets, applicable to the Award, are met. Any value to which the participants are eligible in respect of the Award will be granted as Restricted Share Units (each an “RSU”), with each RSU entitling a participant to receive common shares in the Corporation. Each RSU will be granted under, and governed in accordance with, the rules of the Corporation’s Restricted Share Unit Plan.

Award Date

October 13, 2023

Initial Price

CAD 0.552

Hurdle Rate

10% p.a. above the Initial Price

Total Pool

10% of the growth in value above the Hurdle rate, not exceeding 10% of the Corporation’s share capital.
The number of shares will be determined at the Measurement Dates.

Participant proportion

Edward Wyvill, Corporate Development, 10%

Performance Period

January 1, 2022 to December 31, 2025 (inclusive)

Normal Measurement Dates

First Measurement Date: December 31, 2023, 50% vesting on the first anniversary of grant, with the remaining 50% vesting on the third anniversary of grant.
Second Measurement Date: December 31, 2024, 50% vesting on the first anniversary of grant, with the remaining 50% vesting on the second anniversary of grant.
Third Measurement Date: December 31, 2025, vesting on the first anniversary of grant.

On August 14, 2024, Amaroq made an award (the “Award”) under the RSU Plan as detailed below. The Award consists of a conditional right to receive value if the future performance targets, applicable to the Award, are met. Any value to which the participants are eligible in respect of the Award will be granted as Restricted Share Units (each an “RSU”), with each RSU entitling a participant to receive common shares in the Corporation. Each RSU will be granted under, and governed in accordance with, the rules of the Corporation’s Restricted Share Unit Plan.

Award Date

August 14, 2024

Initial Price

CAD 1.04

Hurdle Rate

10% p.a. above the Initial Price

Total Pool

10% of the growth in value above the Hurdle rate, not exceeding 10% of the Corporation’s share capital.
The number of shares will be determined at the Measurement Date.

Participant proportion

Ellert Arnarson, Chief Financial Officer, 12%

Performance Period

August 6, 2024, to December 31, 2025 (inclusive)

Measurement Date

December 31, 2025, vesting on the first anniversary of grant.

RSU Grant Date

First quarter of 2026

RSU Vesting Date

100% of the shares will vest on the first anniversary of grant (first quarter of 2027)

9. STOCK-BASED COMPENSATION (CONT’d)

9.2.4 Valuation

The fair value of the award granted in December 2022 and modified June 2023, in addition to the award granted October 13, 2023, increased to $7,378,000 based on 90% of the available pool being awarded.

During June 2024, some of the awards were forfeited due to the departure of Jaco Crouse, CFO of the Corporation, effective June 3, 2024 (see note 9.2.5). As a result of the departure, previously recognised RSU award vesting charges of $566,875 were reversed and the percentage of the pool that was allocated was reduced to 70%.

During August 2024, new awards granted to the CFO increased the percentage of the pool that was allocated to 82%.

A charge of $610,654 and $1,328,904 was recorded during the three and nine months ended September 30, 2024 respectively, including the reduction of $566,875 of previously recognized RSU vesting charges which were reversed during the period as a result of the forfeiture of the RSU awards (a charge of $449,000 and $1,347,000 was recorded during the three and nine months ended September 30, 2023).

The fair value was obtained through the use of a Monte Carlo simulation model which calculates a fair value based on a large number of randomly generated projections of the Corporation’s share price.

Assumption

Value

Grant date

December 30, 2022

Amendment date

June 15, 2023

Additional award date

October 13, 2023

Forfeiture of 20% of the awards date

June 3, 2024

Additional award date

August 14, 2024

Expected life (years)

1.38 – 3.00

Share price at grant date

$0.70 – $1.02

Exercise price

N/A

Dividend yield

0%

Risk-free rate

3.44% – 4.71%

Volatility

49.5% – 72%

Fair value of awards – First Measurement Date

$3,538,000

Fair value of awards – Second Measurement Date

$1,526,000

Fair value of awards – Third Measurement Date

$1,496,000

Total fair value of awards (82% of pool)

$6,560,000

Expected volatility was determined from the daily share price volatility over a historical period prior to the date of grant with length commensurate with the expected life. A zero-dividend yield has been used based on the dividend yield as at the date of grant.

9. STOCK-BASED COMPENSATION (CONT’d)

9.2.5 Awards under Restricted Share Unit Plan (the “RSU”)

On February 23, 2024, in alignment with the Company’s RSU plan dated 15 June 2023, the Company granted an award (the “Award”) to directors and employees of the Company as listed below.

Award Date

February 23, 2024

Initial Price

CAD 0.552

Hurdle Rate

10% p.a. above the Initial Price

Total Pool

10% of the growth in value above the Hurdle rate, not exceeding 10% of the Company’s share capital
The number of shares is determined at the Measurement Dates

Participant proportions and Number of shares
subject to RSU

 

 

 

 

Eldur Olafsson, CEO                    40%        3,805,377 shares

Jaco Crouse1, CFO                         20%        1,902,688 shares

Joan Plant, Executive VP               10%        951,344 shares

James Gilbertson, VP Exploration         10%        951,344 shares

Edward Wyvill, Corporate Development        10%        951,344 shares

First Measurement Date:

31 December 2023
50% of the Shares will vest on the first anniversary of grant, with the remaining 50% vesting on the third anniversary of grant.

1The shares awarded under the RSU to Jaco Crouse, CFO, have been forfeited as a result of his departure effective June 3, 2024.

10. EXPLORATION AND EVALUATION EXPENSES (RECOVERY)

 

Three months ended September 30,

Nine months ended September 30,

 

2024

2023

2024

2023

 

$

$

$

$

Geology

440,058

201,738

573,208

176,116

Drilling

2,028,481

173,776

2,088,481

1,210,428

Lodging and on-site support

284,812

151,495

284,812

203,208

Analysis

60,176

27,416

193,086

1,061

Geophysical survey

(416,177)

Transport

14,059

25,510

18,968

650,263

Helicopter charter

805,327

205,073

805,327

886,755

Logistic support

(51,509)

Insurance

Maintenance infrastructure

363,154

628,733

379,986

1,207,624

Supplies and equipment

180,338

706,545

230,849

1,309,562

Project Engineering

55,792

Government fees

8,750

41,599

25,615

Exploration and evaluation expenses before depreciation

4,185,155

2,120,286

4,616,316

5,258,738

Depreciation

239,752

157,254

556,631

478,519

Exploration and evaluation expenses

4,424,907

2,277,540

5,172,947

5,737,257

11. GENERAL AND ADMINISTRATION

 

Three months ended September 30,

Nine months ended September 30,

 

2024

2023

2024

2023

 

$

$

$

$

Salaries and benefits

924,737

626,384

3,916,009

1,864,046

Director’s fees

159,000

158,667

477,000

472,667

Professional fees

793,524

296,024

2,645,492

1,818,781

Marketing and investor relations

169,781

173,572

482,952

480,258

Insurance

83,536

76,002

256,369

211,206

Travel and other expenses

534,375

471,992

1,778,834

993,167

Regulatory fees

214,236

342,668

796,695

715,222

General and administration before following elements

2,879,189

2,145,309

10,353,351

6,555,347

Stock-based compensation

611,185

451,014

1,347,598

1,353,042

Depreciation

45,866

35,718

130,208

106,990

General and administration

3,536,240

2,632,041

11,831,157

8,015,379

12.             FINANCE COSTS

 

Three months ended September 30,

Nine months ended September 30,

 

2024

2023

2024

2023

 

$

$

$

$

Transaction costs and service fees

1,013,771

1,013,771

Lease interest

9,317

8,487

27,449

26,062

 

9,317

1,022,258

27,449

1,039,833

13.        RELATED PARTY TRANSACTIONS AND KEY MANAGEMENT COMPENSATION

13.1 Gardaq Joint Venture

 

Three months ended September 30,

Nine months ended September 30,

 

2024

2023

2024

2023

 

$

$

$

$

Gardaq management fees and allocated cost

608,392

601,461

1,823,286

1,108,101

Other allocated costs

212,489

803,567

388,152

2,516,430

Foreign exchange revaluation

(34,116)

17,480

28,811

16,581

 

786,765

1,422,508

2,240,249

3,641,112

As at September 30, 2024, the balance receivable from Gardaq amounted to $5,762,187 ($3,521,938 as at December 31, 2023). This receivable balance represents allocated overhead and general administration costs to manage the exploration work programmes and day-to-day activities of the joint venture. This balance will be converted to shares in Gardaq within 10 business days after the third anniversary of the completion of the Subscription and Shareholder Agreement dated April 13, 2023 (See note 3.1).

13.        RELATED PARTY TRANSACTIONS AND KEY MANAGEMENT COMPENSATION (CONT’d)

13.2 Key Management Compensation

The Corporation’s key management are the members of the board of directors, the President and Chief Executive Officer, the Chief Financial Officer, the Vice President Exploration, and the Executive Vice President. Key management compensation is as follows:

 

Three months ended September 30,

Nine months ended September 30,

 

2024

2023

2024

2023

 

$

$

$

$

Short-term benefits 

       

Salaries and benefits 

385,277

316,736

1,225,843

971,553

Director’s fees 

159,000

158,667

477,000

472,667

Long-term benefits 

       

Stock-based compensation

531

2,014

2,143

6,042

Stock-based compensation – RSU

610,654

449,000

1,328,904

1,347,000

Total compensation 

1,155,462

926,417

3,033,890

2,797,262

14. NET EARNINGS (LOSS) PER COMMON SHARE

The calculation of net loss per share is shown in the table below.

 

Three months ended September 30,

Nine months ended September 30,

 

2024

2023

2024

2023

 

$

$

$

$

Net income (loss) and comprehensive income (loss)

(14,013,519)

(6,555,222)

(18,001,712)

13,425,594

         

Weighted average number of common shares outstanding – basic

327,418,727

263,579,331

314,985,260

263,356,034

Weighted average number of common shares outstanding – diluted

327,418,727

306,335,274

314,985,260

306,111,977

Basic earnings (loss) per share

(0.043)

(0.02)

(0.057)

0.05

Diluted earnings (loss) per common share

(0.043)

(0.02)

(0.057)

0.04

15. FINANCIAL INSTRUMENTS AND RISK MANAGEMENT

The Corporation is exposed to various risks through its financial instruments. The following analysis provides a summary of the Corporation’s exposure to and concentrations of risk at September 30, 2024:

15.1 Credit Risk

Credit risk is the risk that one party to a financial instrument will cause financial loss for the other party by failing to discharge an obligation. The Corporation’s main credit risk relates to its prepaid amounts to suppliers for placing orders, manufacturing and delivery of process plant equipment, as well as an advance payment to a mining contractor. The Corporation performed expected credit loss assessment and assessed the amounts to be fully recoverable.

15. FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (CONT’d)

15.2 Fair Value

Financial assets and liabilities recognized or disclosed at fair value are classified in the fair value hierarchy based upon the nature of the inputs used in the determination of fair value. The levels of the fair value hierarchy are:

•        Level 1 – Quoted prices (unadjusted) in active markets for identical assets or liabilities
•  Level 2 – Inputs other than quoted prices included within level 1 that are observable for the asset or liability, either directly (i.e., as prices) or indirectly (i.e., derived from prices)
•        Level 3 – Inputs for the asset or liability that are not based on observable market data (i.e., unobservable inputs)

The following table summarizes the carrying value of the Corporation’s financial instruments:

 

September 30,
2024

December 31, 2023

  

$

$

 

Cash

25,937,983

21,014,633

Sales tax receivable

72,087

69,756

Prepaid expenses and others

17,812,986    

18,681,568

Interest receivable

876,478

Deposit

177,944

27,944

Escrow account for environmental monitoring

6,872,073

598,939

Financial Asset – Related Party

5,762,187

3,521,938

Investment in equity-accounted joint arrangement

16,794,261

23,492,811

Accounts payable and accrued liabilities

(13,479,402)

(6,273,979)

Convertible notes

(38,395,349)

(35,743,127)

Loan payable

(24,525,317)   

Lease liabilities

(738,960)

(657,440)

Due to the short-term maturities of cash, prepaid expenses, and accounts payable and accrued liabilities, the carrying amounts of these financial instruments approximate fair value at the respective balance sheet date.

The carrying value of the convertible note instrument approximates its fair value at maturity and includes the embedded derivative associated with the early conversion option and the host liability at amortized cost.

The carrying value of the loan payable approximate its fair value.

The carrying value of lease liabilities approximate its fair value based upon a discounted cash flows method using a discount rate that reflects the Corporation’s borrowing rate at the end of the period.

15. FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (CONT’d)

15.3 Liquidity Risk

Liquidity risk is the risk that the Corporation will encounter difficulty in meeting obligations associated with financial liabilities. The Corporation seeks to ensure that it has sufficient capital to meet short-term financial obligations after taking into account its exploration and operating obligations and cash on hand. The Corporation is currently negotiating new Head of Terms with Landsbankinn in order to fund general and administrative costs, exploration and evaluation costs and Nalunaq project development costs. The Corporation’s options to enhance liquidity include the issuance of new equity instruments or debt.

The following table summarizes the carrying amounts and contractual maturities of financial liabilities:

 

As at September 30, 2024

 

As at December 31, 2023

 

 

Trade and other payables

Convertible notes

Loan payable

Lease liabilities

Trade and other payables

Convertible Notes

Lease liabilities

 

$

$

$

$

$

$

$

Within 1 year

13,479,402

38,395,349

24,525,317

150,250

6,273,979

108,345

1 to 5 years

545,633

35,743,127

544,178

5 to 10 years

154,184

126,975

Total

13,479,402

38,395,349

24,525,317

850,067

6,273,979

35,743,127

779,498

The Corporation has assessed that it is not exposed to significant liquidity risk due to its cash balance in the amount of $25,937,983 at the period end and to the subsequent conversion of the convertible note into shares of the Corporation (see note 16).

16. SUBSEQUENT EVENTS

Amendments and conversion of convertible notes

On October 4, 2024, the Corporation entered into an agreement with the holders of its US $22.4M convertible notes, due in 2027, to convert the notes into new common shares in order to simplify the Corporation’s capital structure, reduce cash interest costs and permit future financial flexibility.

The Corporation has amended the convertible notes to permit the payment of the outstanding interest and commitment fees in common shares of the Corporation at a conversion price equal to the closing price of the common shares on the TSX-V on the trading day immediately prior to such conversion. These amendments were approved by the TSX-V on October 14, 2024.

The holders of the convertible notes have elected to convert all of the outstanding principal of the convertible notes into 33,629,068 Common Shares (the “Principal Conversion Shares”) at a conversion price of CAD 0.90 (£0.525) per Principal Conversion Share and all of the outstanding interest of the convertible notes in 1,293,356 Common Shares (the “Interest Conversion Shares”) at a conversion price of CAD $1.3 (£0.73) per Interest Conversion Share. The Corporation and the holders of the convertible notes also agreed to make 70% of the total amount of the outstanding commitment fee immediately payable. The holders of the convertible notes have elected to convert such commitment fee payable into 3,307,502 Common Shares (the “Commitment Fee Conversion Shares”) in aggregate, at a conversion price of CAD $1.3 (£0.73) per Commitment Fee Conversion Share.

Following the consent of the TSX-V, and their approval of the amendments to the convertible notes, the 33,629,068 Principal Conversion Shares, 1,293,356 Interest Conversion Shares and 3,307,502 Commitment Fee Conversion Shares were admitted to trading on AIM, and TSX-V and Nasdaq Iceland’s main market.


© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

US Stocks Settle Mixed Following Inflation Data: Investor Sentiment Improves, But Fear Index Remains In 'Greed' Zone

The CNN Money Fear and Greed index showed a slight improvement in the overall market sentiment, while the index remained in the “Greed” zone on Wednesday.

U.S. stocks settled mixed on Wednesday, as investors digested the recent inflation data. The U.S. annual inflation rate rose to 2.6% in October from 2.4% in the previous month, in line with market estimates. The CPI rose 0.2% month-over-month in October.

Shares of Rumble Inc. RUM fell around 10% on Wednesday after the company posted downbeat third-quarter results. CyberArk Software Ltd CYBR reported better-than-expected earnings for its third quarter.

Most sectors on the S&P 500 closed on a positive note, with consumer discretionary, energy, and real estate stocks recording the biggest gains on Wednesday. However, information technology and communication services stocks bucked the overall market trend, closing the session lower.

The Dow Jones closed higher by around 47 points to 43,958.19 on Wednesday. The S&P 500 rose 0.02% to 5,985.38, while the Nasdaq Composite fell 0.26% at 19,230.73 during Wednesday’s session.

Investors are awaiting earnings results from The Walt Disney Company DIS, Advance Auto Parts, Inc. AAP, and Applied Materials, Inc. AMAT today.

What is CNN Business Fear & Greed Index?

At a current reading of 67.5, the index remained in the “Greed” zone on Wednesday, versus a prior reading of 66.5.

The Fear & Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.

Read Next:

Photo courtesy: Shutterstock

Market News and Data brought to you by Benzinga APIs

[Latest] Global Formic Acid Market Size/Share Worth USD 5,240 Million by 2033 at a 9.53% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

Austin, TX, USA, Nov. 14, 2024 (GLOBE NEWSWIRE) — Custom Market Insights has published a new research report titled Formic Acid Market Size, Trends and Insights By Grade Type (Grade 85%, Grade 94%, Grade 99%, Others), By Application (Animal Feed, Silage, Leather tanning, Textile dyeing), By End-Users (Agriculture, Pharmaceutical, Others), and By Region – Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033 in its research database.

“According to the latest research study, the demand of global Formic Acid Market size & share was valued at approximately USD 2,110 Million in 2023 and is expected to reach USD 2,310 Million in 2024 and is expected to reach a value of around USD 5,240 Million by 2033, at a compound annual growth rate (CAGR) of about 9.53% during the forecast period 2024 to 2033.”

Click Here to Access a Free Sample Report of the Global Formic Acid Market @ https://www.custommarketinsights.com/request-for-free-sample/?reportid=54357

Formic Acid Market: Growth Factors and Dynamics

  • Rising Demand from the Animal Feed Industry: Formic acid is widely utilized as a preservative and acidifier in animal feed to help prevent the formation of harmful microbes and bacteria. This is especially essential in the cattle business, where preserving feed quality and extending shelf life are critical. The rising global consumption of meat and protein, particularly in developing countries such as China and Brazil, is driving demand for high-quality animal feed, increasing the requirement for formic acid.
  • Expansion of the Rubber Industry: Formic acid is used extensively in processing both natural and synthetic rubber. It is used to coagulate latex and in the final synthesis of numerous rubber types, specifically those used to make tires. With rising vehicle ownership and replacement tire demand, the rubber industry is expanding, increasing formic acid use.
  • Increased Usage in Agriculture: Formic acid is used in agriculture as a silage preservative, which helps to preserve the nutritional value of livestock feed while also improving food safety. This is especially important in regions focused on high-value agricultural production and food security.
  • Pharmaceutical and Chemical Industries: Formic acid is an important intermediary in producing several compounds and medications. It regulates pH levels in chemical reactions and acts as a catalyst in the manufacturing of certain chemicals. The continued development in these industries adds to the growing need for formic acid.
  • Eco-Friendly Applications: Formic acid is known for its environmentally favourable characteristics. It is used for de-icing airport runways, providing a more environmentally friendly alternative to standard chemicals. This use is gaining popularity, particularly in regions with harsh winters.

Request a Customized Copy of the Formic Acid Market Report @ https://www.custommarketinsights.com/inquire-for-discount/?reportid=54357

Formic Acid Market: Partnership and Acquisitions

  • In May 2023, Thermo Fisher Scientific announced a partnership with BRIN to improve research infrastructure and capabilities in Indonesia. The connection will include direct engagements between the two organisations, strengthening their partnership. Thermo Fisher will use its expertise and vast portfolio to assist BRIN in increasing its research competencies and capacity.
  • In October 2022, PETRONAS Chemicals Group Berhad (PCG) announced that it had completed the acquisition of Perstorp Holding AB (Perstorp). The acquisition is part of PCG’s plan to increase its footprint in the specialty chemicals market. PCG aims to strengthen its position in Asia Pacific markets by preserving and growing Perstorp’s value, and leveraging its knowledge and staff. PCG also intends to support Perstorp’s expansion plans, including the introduction of Project Air, which aims to reduce carbon emissions through the manufacture of sustainable methanol.
  • In June 2021, Incipio Group announced a strategic sustainability relationship with Eastman Chemical Company. This collaboration will allow Incipio Group to include recycled materials in its brand portfolio while also pursuing sustainable alternatives that preserve durability, clarity, and performance.
  • In May 2022, The Nitto Group emphasizes ESG (Environment, Society, Governance) in its management, committing to carbon neutrality by May 2022. They focus on CO2 capture and storage technologies to reduce emissions. A key project involves producing carbon-negative formic acid from biomass-derived feedstock using CO2 and hydrogen. Nitto’s advanced catalyst enhances production efficiency and lowers costs. This formic acid, used in dairy farming silage, addresses social issues and generates economic value.

Report Scope

Feature of the Report Details
Market Size in 2024 USD 2,310 Million
Projected Market Size in 2033 USD 5,240 Million
Market Size in 2023 USD 2,110 Million
CAGR Growth Rate 9.53% CAGR
Base Year 2023
Forecast Period 2024-2033
Key Segment By Grade Type, Application, End-Users and Region
Report Coverage Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends
Regional Scope North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America
Buying Options Request tailored purchasing options to fulfil your requirements for research.

(A free sample of the Formic Acid report is available upon request; please contact us for more information.)

Our Free Sample Report Consists of the following:

  • Introduction, Overview, and in-depth industry analysis are all included in the 2024 updated report.
  • The COVID-19 Pandemic Outbreak Impact Analysis is included in the package.
  • About 220+ Pages Research Report (Including Recent Research)
  • Provide detailed chapter-by-chapter guidance on the Request.
  • Updated Regional Analysis with a Graphical Representation of Size, Share, and Trends for the Year 2024
  • Includes Tables and figures have been updated.
  • The most recent version of the report includes the Top Market Players, their Business Strategies, Sales Volume, and Revenue Analysis 
  • Custom Market Insights (CMI) research methodology

(Please note that the sample of the Formic Acid report has been modified to include the COVID-19 impact study prior to delivery.)


Request a Customized Copy of the Formic Acid Market Report @ https://www.custommarketinsights.com/report/formic-acid-market/

Formic Acid Market: COVID-19 Analysis

The COVID-19 pandemic has significantly impacted the Formic Acid Market, with the industry experiencing both positive and negative effects. Here are some of the key impacts:

  • Supply Chain Disruptions: Like many industries, the formic acid market faced supply chain disruptions during the pandemic. Restrictions on movement, reduced workforce availability, and logistical challenges affected the production and distribution of formic acid.
  • Decreased Industrial Activity: Certain industries, such as leather processing and textile manufacturing, which use formic acid in their processes, experienced downturns during the pandemic due to reduced consumer demand and operational disruptions. This led to decreased demand for formic acid in these sectors.
  • Impact on Export/Import: International trade was significantly affected by the pandemic, leading to fluctuations in the availability and pricing of raw materials required for formic acid production. This could have impacted the overall stability of the market.
  • Increased Demand for Disinfectants: Formic acid is used in the production of disinfectants and sanitizers. During the pandemic, there was a surge in demand for these products, leading to increased demand for formic acid.
  • Rising Demand in Pharmaceuticals: Formic acid is also used in pharmaceuticals, such as in the production of certain medications and treatments. The pandemic increased the need for pharmaceutical products, which likely boosted demand for formic acid in this sector.
  • Growth in Animal Feed Preservation: Formic acid is used as a preservative in animal feed. With disruptions in supply chains and concerns about food security during the pandemic, there may have been increased usage of formic acid to preserve animal feed.

In conclusion, the COVID-19 pandemic has had a mixed impact on the Formic Acid Market, with some challenges and opportunities arising from the pandemic.

Request a Customized Copy of the Formic Acid Market Report @ https://www.custommarketinsights.com/report/formic-acid-market/

Key questions answered in this report:

  • What is the size of the Formic Acid market and what is its expected growth rate?
  • What are the primary driving factors that push the Formic Acid market forward?
  • What are the Formic Acid Industry’s top companies?
  • What are the different categories that the Formic Acid Market caters to?
  • What will be the fastest-growing segment or region?
  • In the value chain, what role do essential players play?
  • What is the procedure for getting a free copy of the Formic Acid market sample report and company profiles?

Key Offerings:

  • Market Share, Size & Forecast by Revenue | 2024−2033
  • Market Dynamics – Growth Drivers, Restraints, Investment Opportunities, and Leading Trends
  • Market Segmentation – A detailed analysis by Types of Services, by End-User Services, and by regions
  • Competitive Landscape – Top Key Vendors and Other Prominent Vendors

Buy this Premium Formic Acid Research Report | Fast Delivery Available – [220+ Pages] @ https://www.custommarketinsights.com/report/formic-acid-market/

Formic Acid Market – Regional Analysis

The Formic Acid Market is segmented into various regions, including North America, Europe, Asia-Pacific, and LAMEA. Here is a brief overview of each region:

  • North America: The Key trends driving the growth of the formic acid market in North America include its increasing use as a preservative and antibacterial agent in livestock feed, growing demand in agriculture for silage and animal feed preservation, rising applications in leather and textile industries for tanning and dyeing processes, and the shift towards eco-friendly and sustainable chemicals in various industrial processes. Additionally, the expanding pharmaceutical and food processing sectors also bolster the market’s expansion.
  • Europe: The growth of the Formic Acid market in Europe is supported by several key factors. These include increasing demand from end-use industries such as agriculture, leather, and textiles due to its diverse applications as a preservative, pH adjuster, and antibacterial agent. Additionally, stringent regulations favouring sustainable and eco-friendly products have boosted its adoption. Moreover, ongoing research and development efforts aimed at enhancing production efficiency and expanding application scope are further driving market expansion in the region.
  • Asia-Pacific: The Formic Acid market in Asia-Pacific is buoyed by several key trends. Increasing demand in agriculture for feed preservation and pest control drives growth, alongside its use in leather and textile industries. Rising environmental concerns favour formic acid’s role as a green alternative in industrial processes. Additionally, the region’s robust manufacturing sector and expanding applications in pharmaceuticals and rubber production further propel market expansion. Regulatory support for sustainable practices and technological advancements in production methods are also contributing factors in its increasing adoption across Asia-Pacific.
  • LAMEA (Latin America, Middle East, and Africa): In the LAMEA region, the growth of the Formic Acid market is supported by factors such as increasing industrial applications in agriculture and leather industries, rising demand for preservatives and antibacterial agents, and expanding animal feed additives sector. Additionally, advancements in production technologies and government initiatives promoting sustainable agricultural practices further drive market expansion.

Request a Customized Copy of the Formic Acid Market Report @ https://www.custommarketinsights.com/report/formic-acid-market/

(We customized your report to meet your specific research requirements. Inquire with our sales team about customizing your report.)

Still, Looking for More Information? Do OR Want Data for Inclusion in magazines, case studies, research papers, or Media? 

Email Directly Here with Detail Information: support@custommarketinsights.com

Browse the full Formic Acid Market Size, Trends and Insights By Grade Type (Grade 85%, Grade 94%, Grade 99%, Others), By Application (Animal Feed, Silage, Leather tanning, Textile dyeing), By End-Users (Agriculture, Pharmaceutical, Others), and By Region – Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033 Report at https://www.custommarketinsights.com/report/formic-acid-market/

List of the prominent players in the Formic Acid Market:

  • BASF SE
  • Celanese Corporation
  • Chongqing Chuandong Chemical (Group) Co. Ltd.
  • Eastman Chemical Company
  • Feicheng Acid Chemicals Co. Ltd.
  • Fleurchem Inc.
  • Gujarat Narmada Valley Fertilizers & Chemicals Ltd. (GNFC)
  • Kemira Oyj
  • LUXI Group Co. Ltd.
  • Perstorp Holding AB
  • Yara International ASA
  • Perstorp
  • Eastman Chemical Company
  • Anhui Asahi Kasei Chemical
  • Shandong Acid Technology Co.
  • Others

Click Here to Access a Free Sample Report of the Global Formic Acid Market @ https://www.custommarketinsights.com/report/formic-acid-market/

Spectacular Deals

  • Comprehensive coverage
  • Maximum number of market tables and figures
  • The subscription-based option is offered.
  • Best price guarantee
  • Free 35% or 60 hours of customization.
  • Free post-sale service assistance.
  • 25% discount on your next purchase.
  • Service guarantees are available.
  • Personalized market brief by author.

Browse More Related Reports: 

Sulphur and Sulfuric Acid Market: Sulphur and Sulfuric Acid Market Size, Trends and Insights By Raw Material (Elemental Sulphur, Sulphur Dioxide, Sulphuric Acid, Base Metal Smelters, Pyrite Ore, Others), By Application (Fertilizers, Chemical Manufacturing, Pharmaceuticals, Metal Processing, Petroleum Refining, Textile Industry, Automotive, Pulp & Paper, Others), and By Region – Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033

Metal Powders for Additive Manufacturing Market: Metal Powders for Additive Manufacturing Market Size, Trends and Insights By Manufacturing Technique (Powder Bed, Blown Powder, Others), By Material (Alloys, Stainless Steel, Others), By Application (Aerospace, Automotive, Medical, Oil & Gas, Energy, Others), and By Region – Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033

Aromatherapy Essential Oils Market: Aromatherapy Essential Oils Market Size, Trends and Insights By Product Type (Essential Oils, Carrier Oils, Blended Oils, Others), By Application (Relaxation and Stress Management, Skin and Hair Care, Pain Relief and Anti-inflammatory, Others), By Distribution Channel (Online Retail, Specialty Stores, Supermarkets and Hypermarkets, Others), By End-Use (Household Consumers, Spa and Wellness Centers, Medical and Healthcare Facilities, Others), and By Region – Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033

Synthetic Ethanol Market: Synthetic Ethanol Market Size, Trends and Insights By Feedstock (Starch, Sugar, Cellulose Based, Others), By Application (Fuel & Fuel Additives, Industrial Solvents, Beverages, Disinfectant, Personal Care, Others), and By Region – Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033

US Building Insulation Market: US Building Insulation Market Size, Trends and Insights By Type (Mineral Wool, Glass Wool, Stone Wool, Foamed Plastics, Expanded Polystyrene (EPS), Extruded Polystyrene (XPS), Polyurethane (PU), Polyisocyanurate (PIR), Other, Fiberglass, Cellulose, Aerogels, Others), By Application (Floor Basement, Wall, Roof Ceiling), By End User (Residential, Non-Residential, Industrial, Commercial, Others), and By Region – Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033

Acoustic Ceiling Tiles Market: Acoustic Ceiling Tiles Market Size, Trends and Insights By Type (Mineral Wool Ceiling Tiles, Metal Ceiling Tiles, Gypsum Ceiling Tiles, Wood Ceiling Tiles, Others), By Application (Commercial Buildings, Educational Institutions, Healthcare Facilities, Industrial Settings, Others), By End User (Architects and Interior Designers, Building Contractors, Facility Managers, Others), and By Region – Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033

North America Spoolable Pipe Market: North America Spoolable Pipe Market Size, Trends and Insights By Product Type (Flexible Spoolable Pipe, Rigid Spoolable Pipe), By Reinforcement Type (Fiber Reinforcement, Glass Reinforcement, Carbon Reinforcement, Other Reinforcement, Steel Reinforcement, Hybrid Reinforcement), By Application (Onshore, Production and Gathering Lines, Injection Pipes, Disposal Lines, Others, Offshore, Flowlines, Jumpers, Others, Downhole, Water, Others), By End User (Oil & Gas, Municipalities, Mining, Chemical & Petrochemical, Food Processing, Others), and By Region – Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033

Europe Building Insulation Market: Europe Building Insulation Market Size, Trends and Insights By Type (Mineral Wool, Glass Wool, Stone Wool, Foamed Plastics, Expanded Polystyrene (EPS), Extruded Polystyrene (XPS), Polyurethane (PU), Polyisocyanurate (PIR), Other, Fiberglass, Cellulose, Aerogels, Others), By Application (Floor Basement, Wall, Roof Ceiling), By End User (Residential, Non-Residential, Industrial, Commercial, Others), and By Region – Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033

The Formic Acid Market is segmented as follows:

By Grade Type

  • Grade 85%
  • Grade 94%
  • Grade 99%
  • Others

By Application

  • Animal Feed
  • Silage
  • Leather tanning
  • Textile dyeing

By End-Users

  • Agriculture
  • Pharmaceutical
  • Others

Click Here to Get a Free Sample Report of the Global Formic Acid Market @ https://www.custommarketinsights.com/report/formic-acid-market/

Regional Coverage:

North America

  • U.S.
  • Canada
  • Mexico
  • Rest of North America

Europe

  • Germany
  • France
  • U.K.
  • Russia
  • Italy
  • Spain
  • Netherlands
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • New Zealand
  • Australia
  • South Korea
  • Taiwan
  • Rest of Asia Pacific

The Middle East & Africa

  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of the Middle East & Africa

Latin America

  • Brazil
  • Argentina
  • Rest of Latin America

This Formic Acid Market Research/Analysis Report Contains Answers to the following Questions.

  • Which Trends Are Causing These Developments?
  • Who Are the Global Key Players in This Formic Acid Market? What are Their Company Profile, Product Information, and Contact Information?
  • What Was the Global Market Status of the Formic Acid Market? What Was the Capacity, Production Value, Cost and PROFIT of the Formic Acid Market?
  • What Is the Current Market Status of the Formic Acid Industry? What’s Market Competition in This Industry, Both Company and Country Wise? What’s Market Analysis of Formic Acid Market by Considering Applications and Types?
  • What Are Projections of the Global Formic Acid Industry Considering Capacity, Production and Production Value? What Will Be the Estimation of Cost and Profit? What Will Be Market Share, Supply and Consumption? What about imports and exports?
  • What Is Formic Acid Market Chain Analysis by Upstream Raw Materials and Downstream Industry?
  • What Is the Economic Impact On Formic Acid Industry? What are Global Macroeconomic Environment Analysis Results? What Are Global Macroeconomic Environment Development Trends?
  • What Are Market Dynamics of Formic Acid Market? What Are Challenges and Opportunities?
  • What Should Be Entry Strategies, Countermeasures to Economic Impact, and Marketing Channels for Formic Acid Industry?

Click Here to Access a Free Sample Report of the Global Formic Acid Market @ https://www.custommarketinsights.com/report/formic-acid-market/

Reasons to Purchase Formic Acid Market Report

  • Formic Acid Market Report provides qualitative and quantitative analysis of the market based on segmentation involving economic and non-economic factors.
  • Formic Acid Market report outlines market value (USD) data for each segment and sub-segment.
  • This report indicates the region and segment expected to witness the fastest growth and dominate the market.
  • Formic Acid Market Analysis by geography highlights the consumption of the product/service in the region and indicates the factors affecting the market within each region.
  • The competitive landscape incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled.
  • Extensive company profiles comprising company overview, company insights, product benchmarking, and SWOT analysis for the major market players.
  • The Industry’s current and future market outlook concerning recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging and developed regions.
  • Formic Acid Market Includes in-depth market analysis from various perspectives through Porter’s five forces analysis and provides insight into the market through Value Chain.

Reasons for the Research Report

  • The study provides a thorough overview of the global Formic Acid market. Compare your performance to that of the market as a whole.
  • Aim to maintain competitiveness while innovations from established key players fuel market growth.

Buy this Premium Formic Acid Research Report | Fast Delivery Available – [220+ Pages] @  https://www.custommarketinsights.com/report/formic-acid-market/

What does the report include?

  • Drivers, restrictions, and opportunities are among the qualitative elements covered in the worldwide Formic Acid market analysis.
  • The competitive environment of current and potential participants in the Formic Acid market is covered in the report, as well as those companies’ strategic product development ambitions.
  • According to the component, application, and industry vertical, this study analyzes the market qualitatively and quantitatively. Additionally, the report offers comparable data for the important regions.
  • For each segment mentioned above, actual market sizes and forecasts have been given.

Who should buy this report?

  • Participants and stakeholders worldwide Formic Acid market should find this report useful. The research will be useful to all market participants in the Formic Acid industry.
  • Managers in the Formic Acid sector are interested in publishing up-to-date and projected data about the worldwide Formic Acid market.
  • Governmental agencies, regulatory bodies, decision-makers, and organizations want to invest in Formic Acid products’ market trends.
  • Market insights are sought for by analysts, researchers, educators, strategy managers, and government organizations to develop plans. 

Request a Customized Copy of the Formic Acid Market Report @ https://www.custommarketinsights.com/report/formic-acid-market/

About Custom Market Insights:

Custom Market Insights is a market research and advisory company delivering business insights and market research reports to large, small, and medium-scale enterprises. We assist clients with strategies and business policies and regularly work towards achieving sustainable growth in their respective domains.

CMI provides a one-stop solution for data collection to investment advice. The expert analysis of our company digs out essential factors that help to understand the significance and impact of market dynamics. The professional experts apply clients inside on the aspects such as strategies for future estimation fall, forecasting or opportunity to grow, and consumer survey.

Follow Us: LinkedIn | Twitter | Facebook | YouTube

Contact Us:

Joel John

CMI Consulting LLC

1333, 701 Tillery Street Unit 12,

Austin, TX, Travis, US, 78702

USA: +1 801-639-9061

India: +91 20 46022736

Email: support@custommarketinsights.com

Web: https://www.custommarketinsights.com/

Blog: https://www.techyounme.com/

Blog: https://atozresearch.com/

Blog: https://www.technowalla.com/

Blog: https://marketresearchtrade.com/

Buy this Premium Formic Acid Research Report | Fast Delivery Available – [220+ Pages] @ https://www.custommarketinsights.com/report/formic-acid-market/


Primary Logo

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Disney, Cisco And 3 Stocks To Watch Heading Into Thursday

With U.S. stock futures trading lower this morning on Thursday, some of the stocks that may grab investor focus today are as follows:

  • Wall Street expects The Walt Disney Company DIS to report quarterly earnings at $1.10 per share on revenue of $22.35 billion before the opening bell, according to data from Benzinga Pro. Disney shares rose 0.6% to $103.30 in after-hours trading.
  • Cisco Systems Inc. CSCO reported better-than-expected results for its first quarter and raised its full-year 2025 guidance. The company reported first-quarter revenue of $13.84 billion, beating the consensus estimate of $13.77 billion. The networking equipment maker reported adjusted earnings of 91 cents per share, beating analyst estimates of 87 cents per share. Cisco shares fell 2.9% to $57.45 in the after-hours trading session.
  • Analysts are expecting Advance Auto Parts, Inc. AAP to post quarterly earnings at 49 per share on revenue of $2.65 billion. The company will release earnings before the markets open. Advance Auto Parts shares fell 0.2% to $40.85 in after-hours trading.

Check out our premarket coverage here

  • Helmerich & Payne, Inc. HP reported worse-than-expected fourth-quarter earnings and sales results on Wednesday. Helmerich & Payne shares fell 3.3% to $35.00 in the after-hours trading session.
  • Analysts expect Applied Materials, Inc. AMAT to report quarterly earnings at $2.19 per share on revenue of $6.95 billion after the closing bell. Applied Materials shares gained 0.2% to $183.22 in after-hours trading.

Check This Out:

Photo courtesy: Unsplash

Market News and Data brought to you by Benzinga APIs

Advance Auto Parts Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Advance Auto Parts, Inc. AAP will release earnings results for its third quarter, before the opening bell on Thursday, Nov. 14.

Analysts expect the Raleigh, North Carolina-based company to report quarterly earnings at 54 cents per share, versus a year-ago loss of 82 cents per share. Advance Auto Parts projects to report revenue of $2.67 billion for the quarter, compared to $2.72 billion a year earlier, according to data from Benzinga Pro.

On Nov. 4, Advance Auto Parts announced the close of the sale of Worldpac, Inc. to global investment firm Carlyle CG.

Advance Auto Parts shares gained 2.6% to close at $40.94 on Wednesday.

Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.

Let’s have a look at how Benzinga’s most-accurate analysts have rated the company in the recent period.

  • RBC Capital analyst Steven Shemesh maintained a Sector Perform rating and cut the price target from $52 to $46 on Nov. 11. This analyst has an accuracy rate of 65%.
  • Truist Securities analyst Scott Ciccarelli maintained a Hold rating and lowered the price target from $46 to $41 on Nov. 7. This analyst has an accuracy rate of 78%.
  • Evercore ISI Group analyst Greg Melich maintained an In-Line rating and decreased the price target from $71 to $67 on Oct. 22. This analyst has an accuracy rate of 80%.
  • Wedbush analyst Seth Basham upgraded the stock from Neutral to Outperform on Oct. 15. This analyst has an accuracy rate of 69%.
  • Wells Fargo analyst Zachary Fadem maintained an Equal-Weight rating and slashed the price target from $50 to $40 on Sept. 13. This analyst has an accuracy rate of 73%.

Considering buying AAP stock? Here’s what analysts think:

Read This Next:

Market News and Data brought to you by Benzinga APIs